financetom
Business
financetom
/
Business
/
Rossari Biotech expects 15% growth in FY21; health, hygiene key focus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rossari Biotech expects 15% growth in FY21; health, hygiene key focus
Oct 27, 2020 3:55 AM

Rossari Biotech posted a strong quarter, with strong performance by the textile specialty chemicals segment. Operational performance improved quite a bit with margins coming in at almost 22 percent versus 17.50 percent same time last year.

Share Market Live

NSE

In an interview with CNBC-TV18, Sunil Chari, Promoter and MD at Rossari Biotech, said the company is looking at 15 percent growth this year.

“Our home, personal care and performance chemicals grew quarter-on-quarter (QoQ) over last year and also the first quarter of this year. We see focus on health and hygiene remaining forever I think,” he said.

“We are conscious of our health and this pandemic has brought this on the forefront. So we being in the products which focus on health and hygiene, we think that we are in times of accelerating growth in the future,” he added.

First Published:Oct 27, 2020 11:55 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
P&G signals sluggish annual growth amid leadership change, tariffs
P&G signals sluggish annual growth amid leadership change, tariffs
Jul 29, 2025
(Reuters) -Procter & Gamble ( PG ) on Tuesday forecast annual results largely below Wall Street estimates in the face of cautious consumers, a day after the Tide parent named an insider as CEO to steer it through the tariff uncertainty. The muted expectations will likely pile pressure on Shailesh Jejurikar, who on Monday was named to the top post...
Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook
Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook
Jul 29, 2025
COPENHAGEN, July 29 (Reuters) - Obesity drugmaker Novo Nordisk warned on Tuesday that full-year sales and operating proft would grow less than previously expected, marking its second forecast cut of 2025. The maker of weight-loss drug Wegovy is struggling to convince investors it can remain competitive in the obesity drug boom against U.S. rival Eli Lilly ( LLY ). Novo...
Union Pacific to buy Norfolk in $85 billion mega US railroad deal
Union Pacific to buy Norfolk in $85 billion mega US railroad deal
Jul 29, 2025
(Reuters) -Union Pacific said on Tuesday it would buy smaller rival Norfolk Southern in an $85 billion deal, to create the nation's first coast-to-coast freight rail operator and reshape the movement of goods from grains to autos across the country. If approved, the deal would combine Union Pacific's stronghold in the western two-thirds of the U.S. with Norfolk's 19,500 mile...
Copyright 2023-2026 - www.financetom.com All Rights Reserved